NRC Health Common Stock
NRC
95 hedge funds and large institutions have $614M invested in NRC Health Common Stock in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 46 increasing their positions, 25 reducing their positions, and 12 closing their positions.
84% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 25
32% more capital invested
Capital invested by funds: $464M → $614M (+$149M)
1.17% more ownership
Funds ownership: 40.73% → 41.9% (+1.2%)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
1% less funds holding
Funds holding: 96 → 95 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$6.79M |
| 2 |
BlackRock
New York
|
+$4.96M |
| 3 |
BG
Bahl & Gaynor
Cincinnati,
Ohio
|
+$2.29M |
| 4 |
Comerica Bank
Dallas,
Texas
|
+$1.96M |
| 5 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$1.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$2.88M |
| 2 |
Renaissance Technologies
New York
|
-$2.08M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$758K |
| 4 |
SRAM
Stone Ridge Asset Management
New York
|
-$709K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$548K |
NRC Hedge Fund Activity: Q2 2020 in Review
95 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q2 2020, worth a combined $614M — up 32% from $464M a quarter earlier.
Fund positioning in NRC was balanced in Q2 2020: 12 funds opened new positions, 12 closed out, 46 added to existing stakes and 25 trimmed.
The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $6.79M. The largest seller was JP Morgan Chase, cutting an estimated $2.88M.
- 95 institutional investors held NRC Health Common Stock (NRC) as of Q2 2020, down from 96 in Q1 2020.
- Funds reported $614M of NRC Health Common Stock stock for Q2 2020, up 32% quarter-over-quarter.
- 12 funds opened new NRC Health Common Stock positions in Q2 2020 and 12 closed out, a net change of 0 holders.
- The largest NRC Health Common Stock buyer in Q2 2020 was Kayne Anderson Rudnick Investment Management, an estimated $6.79M added.
- The largest NRC Health Common Stock seller in Q2 2020 was JP Morgan Chase, an estimated $2.88M sold.
Based on aggregated 13F filings for Q2 2020.